Ooi, C. J., Hilmi, I. N., Kim, H., Jalihal, U., Wu, D., Demuth, D., . . . Adsul, S. (2021). Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study. Intest Res.
Chicago-tyylinen lähdeviittausOoi, Choon Jin, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, ja Shashi Adsul. "Efficacy and Safety of Vedolizumab in Ulcerative Colitis in Patients From Asian Countries in the GEMINI 1 Study." Intest Res 2021.
MLA-viiteOoi, Choon Jin, et al. "Efficacy and Safety of Vedolizumab in Ulcerative Colitis in Patients From Asian Countries in the GEMINI 1 Study." Intest Res 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.